MELANY's data-driven read on BioNTech SE.
BioNTech is a Germany-based biotechnology company developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases such as covid. Its oncology pipeline spans several drug classes, including mRNA-based drugs encoding antigens and neoantigens, monospecific and bispecific antibodies, and antibody-drug conjugates (ADCs). Its first commercialized product is Comirnaty, the covid vaccine partnered with Pfizer.
Entry zone, stop-loss, price targets, and live alerts unlock when you sign up. No card required.